久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

上海非利加實(shí)業(yè)有限公司Logo

熱門(mén)詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥

當(dāng)前位置: 首頁(yè) > 所有品牌 > VaxInnate
VaxInnate
VaxInnate VaxInnate

美國(guó)VaxInnate
VaxInnate公司是一家私人持有的生物技術(shù)公司,開(kāi)發(fā)新穎,專有疫苗為大流行病和季節(jié)性流感。該公司的突破疫苗是基于其Toll樣受體( TLR為)的技術(shù)平臺(tái),大大提高了疫苗的免疫原性和有效性。利用TLR為技術(shù),疫苗可產(chǎn)生的簡(jiǎn)單,低成本,高可擴(kuò)展性重組DNA技術(shù),避免許多挑戰(zhàn)和隱患的雞蛋或細(xì)胞培養(yǎng)流感疫苗的生產(chǎn)。 VaxInnate的技術(shù)有可能顯著提高成本效益,制造能力和效力的流感疫苗-面臨的關(guān)鍵問(wèn)題的臨床和公共健康的社區(qū)。

美國(guó)生物制藥公司VaxInnate總裁艾倫·肖在接受新華社記者采訪時(shí)表示,針對(duì)這種新型病毒(豬流感病毒)的疫苗樣品有望在4周內(nèi)研制成功。

VaxInnate is a privately-held biotechnology company developing novel, proprietary vaccines for both pandemic and seasonal influenza. The company's breakthrough vaccines are based on its Toll-like receptor (TLR) technology platform, which dramatically improves vaccine immunogenicity and efficacy. Using the TLR technology, vaccines can be produced by simple, low-cost, highly-scalable recombinant DNA techniques, avoiding many of the challenges and pitfalls of egg-based or cell-culture influenza vaccine production. VaxInnate's technology has the potential to significantly improve the cost-effectiveness, manufacturing capacity, and potency of influenza vaccines - key issues facing the clinical and public health communities.

 

VaxInnate has a BSL2+ laboratory operational within the Cranbury site, and also has access to BSL-2 vivarium space through a collaborative research agreement with Yale University . VaxInnate also has a collaborative arrangement with an academic institution for access to high level biocontainment facilities (BSL-3 and -4). Since avian influenza requires BSL-3 or -4 facilities, depending on the strain in question, this access enables the VaxInnate to conduct live virus challenges in animal models.



VaxInnate was founded by Ruslan Medzhitov and Richard Flavell, both of Yale University and Howard Hughes Medical Institute and leaders in the field of innate immunity. The company started in 2002 with Michael Sherman serving as Chief Executive Officer and a research team in New Haven , CT. In 2004, the company expanded and established a development team and corporate headquarters in Cranbury , NJ . The company currently has approximately 58 employees including 18 with doctoral degrees.

 

Currently, VaxInnate occupies approximately 30,000 square feet of laboratory and office space in Cranbury , NJ , and New Haven , CT. This includes molecular and cell biology labs, cell culture facilities, a protein pilot plant and analytical laboratory space.

 

VaxInnate has raised more than $64 million to date and is backed by well-known venture capital firms, including HealthCare Ventures, Oxford Bioscience Partners LLC, MedImmune Ventures, Inc., CHL Medical Partners, New Leaf Venture Partners, and Canaan Partners.


關(guān)于我們客戶服務(wù)產(chǎn)品分類法律聲明
主站蜘蛛池模板: 亚洲一区精品伊人久久 | 精品国产电影在线看免费观看 | 欧美日本一道本 | 国内精品久久久久 | 欧美我不卡 | xxxx性xx另类| 一区二区三区精品牛牛 | 亚洲高清一区二区三区 | 亚洲一区二区在线成人 | 国产区第一页 | 日韩欧美一区二区三区中文精品 | 538精品在线视频 | 一本在线 | 国产成人精品.一二区 | 亚洲色图另类 | 免费精品国产 | 精品一区二区三区四区电影 | 亚洲 欧美 日韩 小说 另类 | 久久精品国产一区二区 | 日本aⅴ精品一区二区三区久久 | 免费一级| 亚洲欧美第一 | 一本久久道 | 91.久久 | 国产欧美在线观看一区二区 | 亚洲精品视频区 | 国产日韩一区二区三区在线观看 | 亚洲欧美另类自拍第一页 | 91.久久| 亚洲高清一区二区三区 | 夜精品a一区二区三区 | 欧美日韩中文在线 | 一区二区三区免费在线 | 亚洲欧美日韩中文无线码 | 日韩视频在线观看一区二区 | 欧美人与性动交a欧美精品 欧美日本一道本 | 欧美一区二区三区不卡免费 | 青草青99久久99九九99九九九 | 毛片一区 | 黄色在线观看免费 | 国产成人精品久久亚洲高清不卡 |